Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Reshma Kewalramani
Age : 48
Public asset : 28,253,510 USD
Country of residence : Unknown
Linked companies : Vertex Pharmaceuticals Incorporated - Ginkgo Bioworks Holdings, Inc.

Biography of Reshma Kewalramani 
Reshma Kewalramani is President, Chief Executive Officer & Director at Vertex Pharmaceuticals, Inc. In the past she was VP-Global Clinical Development & Nephrology at Amgen, Inc. She received a doctorate from Boston University School of Medicine.


Current positions of Reshma Kewalramani 
Holdings of Reshma Kewalramani 
Reshma Kewalramani : Personal Network 
Most Read News 
09/28Buffett's Berkshire Hathaway buys 5.99 million more Occidental shares
RE
09/26Unilever's soap opera: M&A, Nelson Peltz, CEO to retire
RE
09/20JPMorgan CEO Dimon to warn Congress of economic 'storm clouds' -testimony
RE
09/26Twitter to interview Elon Musk, known for combative testimony
RE
09/21Trump ally Barrack's trial on foreign agent charges moves to opening statements
RE
09/29The long, winding road to Volkswagen's Porsche IPO
RE
09/20Palihapitiya to wind down two blank-check firms as choppy markets deter valuations
RE
09/21Bloomberg to spend $85 million against U.S. plastic, petrochem buildout
RE
09/28Elon Musk seeks to narrow SEC consent decree, end pre-approval of tweets
RE
09/21Samsung Elec's Lee says SoftBank's Son expected to visit Seoul -media
RE
More news


© 2022 People and Ownership :   
Reshma Kewalramani : Connections 


Latest news about Reshma Kewalramani 
09/09Transcript : Vertex Pharmaceuticals Incorporated Presents at 2022 Wells Fargo Healthcare Conference, Sep-09-2022 11:00 AM
CI
09/08Vertex Pharmaceuticals Incorporated Appoints Jonathan Biller as Chief Legal Officer, Effective September 19, 2022
CI
08/17Insider Sell: Vertex Pharmaceuticals
MT
08/04Transcript : Vertex Pharmaceuticals Incorporated, Q2 2022 Earnings Call, Aug 04, 2022
CI
06/28Insider Sell: Vertex Pharmaceuticals
MT
06/15Transcript : Vertex Pharmaceuticals Incorporated Presents at Goldman Sachs 43rd Annual Global Healthcare Conference, Jun-15-2022 01:20 PM
CI
05/17Vertex Pharmaceuticals Pledges $50 Million to Health Equity
MT
More news